Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05928377 · ClinicalTrials.gov registry record

Unveiling Patient Experiences in Testicular Cancer Clinical Trials

A clinical trial, sponsored by Power Life Sciences.

Not yet
Registry status
500
Enrollment target

NCT05928377 is a clinical trial that has not yet begun recruiting, run by Power Life Sciences. The registered enrollment target is 500 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05928377 has not yet begun recruiting, sponsored by Power Life Sciences.

NOT YET RECRUITING
Registry status
500 participants
Enrollment target

Study Summary

Clinical research participation has historically been heavily biased toward specific demographics. Several people will be invited to enroll in this study so that it may collect a variety of data about testicular cancer clinical study experiences and identify barriers to participation as well as the causes of participants' failure or withdrawal. People with testicular cancer who are invited to take part in medical research will benefit from the analysis of the data.

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2024-07
Est. Completion 2026-07

Sponsor

Power Life Sciences

62 total trials

What the Registry Record Tells You About NCT05928377

The ClinicalTrials.gov registry entry for NCT05928377 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Power Life Sciences, which has 62 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT05928377 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05928377 about?

NCT05928377 is a clinical study titled "Unveiling Patient Experiences in Testicular Cancer Clinical Trials". Clinical research participation has historically been heavily biased toward specific demographics. Several people will be invited to enroll in this study so that it may collect a variety of data about testicular cancer clinical study experiences and identify barriers to participation as well as the...

What is the current status of trial NCT05928377?

This trial is currently not yet recruiting. The enrollment target is 500 participants. The study started on 2024-07. Estimated completion is 2026-07.

Who is sponsoring clinical trial NCT05928377?

This trial is sponsored by Power Life Sciences, which has 62 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.